Cargando…
Favipiravir-Induced Drug Fever in a Young Adult COVID-19 Patient
Severe acute respiratory syndrome coronavirus 2 has had an indelible effect, with 153,738,171 cases recorded globally as per the World Health Organization’s dashboard. The medical establishment is racing to find repurposed medications that can be successful against this novel coronavirus due to a sh...
Autores principales: | Jadeja, Dhigishaba M, Patel, Nirmit R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189533/ https://www.ncbi.nlm.nih.gov/pubmed/34123627 http://dx.doi.org/10.7759/cureus.14928 |
Ejemplares similares
-
Symptomatic Reinfection in Previously Recovered Coronavirus Disease 2019 (COVID-19) Geriatric Patient
por: Jadeja, Dhigishaba, et al.
Publicado: (2021) -
A Rare Case of Herpes Zoster in an Adult Patient Recovered From Symptomatic Reinfection of COVID-19
por: Ghosh, Binita, et al.
Publicado: (2021) -
Elevation of Serum Transaminase Levels Due to Favipiravir Use in the Treatment of COVID-19
por: Bayram, Mehmet, et al.
Publicado: (2021) -
Efficacy and Safety of Favipiravir in Treating COVID-19 Patients: A Meta-Analysis of Randomized Control Trials
por: Batool, Saima, et al.
Publicado: (2023) -
Cytomegalovirus-Induced Coombs-Positive Hemolysis or Drug-Induced Hemolysis in an Immunocompetent Young Adult
por: Yacoub, Mirna S, et al.
Publicado: (2022)